Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens

REFERENCES

• Anderson , G. M. III , Braun , G. , Braun , U. , Nichols , D. E. and Shulgin , A. T. 1978 . “ Absolute configuration and psychotomimetic activity. ” . In QUASAR: Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens. Edited by: Barnett , G. , Trsic , M. and Willette , R. Rockville , Maryland : NIDA. . NIDA Research Monograph 22
   Google Scholar
• Glennon , R. A. , Rosecrans , J. A. and Young , R. 1982 . “ The use of the drug discrimination paradigm for studying hallucinogenic agents. A review. ” . In Drug Discrimination: Applications in CNS Pharmacology. Edited by: Colpaert , F. C. and Stangen , J. L. Amsterdam : Elsevier. .
   Google Scholar
• Glennon , R. A. and Young , R. Y. 1984a . Further investigation of the discriminative stimulus properties of MDA . Pharmacology, Biochemistry and Behavior , Vol. 20 : 501 – 505 .
   Web of Science ®Google Scholar
• Glennon , R. A. and Young , R. Y. 1984b . MDA: A psychoactive agent with dual stimulus effects . Life Sciences , Vol. 34 : 379 – 383 .
   Web of Science ®Google Scholar
• Glennon , R. A. and Young , R. 1984c . MDA: An agent that produces stimulus effects similar to those of 3,4-DMA, LSD and cocaine . European Journal of Pharmacology , Vol. 99 : 249 – 250 .
   Web of Science ®Google Scholar
• Glennon , R. A. , Young , R. and Rosecrans , J. 1983 . Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists . European Journal of Pharmacology , Vol. 91 : 189 – 196 .
   Web of Science ®Google Scholar
• Glennon , R. A. , Young , R. , Rosecrans , J. A. and Anderson , G. M. III . 1982 . Discriminative stimulus properties of MDA and related agents . Biological Psychiatry , Vol. 17 : 807 – 814 .
   Web of Science ®Google Scholar
• Lyon , R. A. , Glennon , R. A. and Titeler , M. 1986 . 3,4-Methylenedioxymethamphetamine (MDMA): Stereoselective interactions at 5-HT, and 5-HT2 receptors . Psychopharmacology , Vol. 88 : 525 – 526 .
   Web of Science ®Google Scholar
• Moore , K. E. 1978 . “ Amphetamines: Biochemical and behavioral actions in animals. ” . In Handbook of Psychopharmacology. Edited by: Iversen , L. L. , Iversen , S. D. and Snyder , S. H. Vol. 11 , New York : Plenum. .
   Google Scholar
• Naranjo , C. , Shulgin , A. T. and Sargent , T. 1967 . Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct of psychotherapy . Medicinaet Pharmacologia Experimentalis , Vol. 17 : 359 – 364 .
   Google Scholar
• Nichols , D. E. and Glennon , R. A. 1984 . “ Medicinal chemistry and structure-activity relationships of hallucinogens. ” . In Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives. Edited by: Jacobs , B. L. New York : Raven Press. .
   Google Scholar
• Nichols , D. E. , Hoffman , A. J. , Oberlender , R. A. , Jacob , P. III and Shulgin , A. T. 1986 . Derivatives of 1-(1.3-benzodioxol-5-yl)-2-butanamine. Representatives of a novel therapeutic class . Journal of Medicinal Chemistry , Vol. 29 : 2009 – 2015 .
   Web of Science ®Google Scholar
• Nichols , D. E. , Lloyd , D. H. , Hoffman , A. J. , Nichols , M. B. and Yim , G. K. W. 1982 . Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes . Journal of Medicinal Chemistry , Vol. 25 : 530 – 534 .
   Web of Science ®Google Scholar
• Nozaki , M. , Vaupel , D. B. and Martin , W. R. 1977 . A pharmacologic comparison of 3,4-methylenedioxyamphetamine and LSD in the chronic spinal dog . European Journal of Pharmacology , Vol. 46 : 339 – 349 .
   Web of Science ®Google Scholar
• Shulgin , A. T. 1978 . “ Psychotomimetic drugs: Structure-activity relationships. ” . In Handbook of Psychopharmacology. Edited by: Iversen , L. L. , Iversen , S. D. and Snyder , S. H. Vol. 11 , New York : Plenum. .
   Google Scholar
• Shulgin , A. T. 1973 . Stereospecific requirements for hallucinogenesis . Journal of Pharmacy and Pharmacology , Vol. 25 : 271 – 272 .
   Web of Science ®Google Scholar
• Shulgin , A. T. 1963 . Psychotomimetic agents related to mescaline . Experientia , Vol. 19 : 127 – 128 .
   Google Scholar
• Standridge , R. T. , Howell , H. G. , Gylys , J. A. , Partyka , R. A. and Shulgin , A. T. 1976 . Phenylalkylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane . Journal of Medicinal Chemistry , Vol. 19 : 1400 – 1404 .
   Web of Science ®Google Scholar
• Steele , T. D. , Nichols , D. E. and Yim , G. K. W. 1986 . Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related compounds on inhibition of 3H-monoamine uptake into synaptosomes from different regions of rat brain . Biochemical Pharmacology , (submitted for publication)
   PubMed Web of Science ®Google Scholar
• Thiessen , P. N. and Cook , D. A. 1973 . The properties of 3,4-methylenedioxyamphetamine (MDA). II. Studies of acute toxicity in the mouse and protection by various agents . Clinical Toxicology , Vol. 6 : 193 – 199 .
   Web of Science ®Google Scholar
• Whipple , M. R. , Reinecke , M. G. and Gage , F. H. 1983 . Inhibition of synaptosomal neurotransmitter uptake by hallucinogens . Journal of Neurochemistry , Vol. 40 : 1185 – 1188 .
   Web of Science ®Google Scholar
• Winter , J. C. 1980 . Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and SCH-12679, in rats trained with LSD as a discriminative stimulus . Psychopharmacology , Vol. 68 : 159 – 162 .
   Web of Science ®Google Scholar
• Yokel , R. A. and Wise , R. A. 1975 . Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward . Science , Vol. 187 : 547 – 549 .
   Web of Science ®Google Scholar